APOE-Derived Peptides Attenuated Diabetes-Induced Oxidative Stress and Inflammation.
Apolipoprotein-derived peptides have emerged as a potential candidate for the treatment of various inflammatory disease conditions. Previously we have shown that peptides derived from human apolipoprotein-E interact with various pro-inflammatory lipids and inhibit their inflammatory functions in cellular assays. In this study, two peptides (E5 and E8, which corresponds to the 'receptor-binding region' and 'lipid-binding region' of apolipoprotein-E, respectively) were selected to investigate their anti-inflammatory and anti-oxidative effects in streptozotocin-induced diabetic model of inflammation and oxidative stress. 4F peptide, a well-studied apoA1-mimetic peptide that exhibit anti-inflammatory, was also used. Our results suggest that peptides (4F, E5 and E8) are able to reduce oxidative stress as well as lower the level of inflammatory markers in streptozotocin-induced diabetic rats albeit to different extent. E5 peptide was relatively more effective than 4F and E8 peptides in decreasing inflammation and oxidative stress. E5 peptide can be developed as a promising candidate for the treatment of various inflammatory conditions.